In addition, the overall survivals of these genes were also analyzed by applying the Human Protein Atlas datasets, and the results showed that only three genes (ERO1L, CDH3, and FAM83A) were significantly associated with NSCLC patients' overall survivals (Figure 4b). This evidence concerns the gene ERO1A and non-small cell lung carcinoma.